FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

109055007: Octreotide acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173590013 Octreotide acetate en Synonym Active Entire term case insensitive SNOMED CT core module
607692011 Octreotide acetate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide acetate Is a Octreotide false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Acetate false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Product containing octreotide false Inferred relationship Existential restriction modifier
Octreotide acetate Is a Acetate compound false Inferred relationship Existential restriction modifier
Octreotide acetate Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier
Octreotide acetate Is a Cyclic peptide true Inferred relationship Existential restriction modifier
Octreotide acetate Is a Somatostatin analog true Inferred relationship Existential restriction modifier
Octreotide acetate Is modification of Octreotide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide acetate preparation Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 100mcg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 500mcg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 200mcg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 10mg depot injection Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 20mg depot injection Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 30mg depot injection Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 50mcg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide acetate 1mg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/mL injection solution ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 200micrograms/mL injection solution 5mL vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial Has precise active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier 1
Octreotide 500micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 10mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 10mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 200micrograms/mL injection solution 5mL vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Seacross Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Medihealth (Northern) Ltd) Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Medihealth (Northern) Ltd) 5 pre-filled disposable injection Has specific active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) Has active ingredient True Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Sun Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier
Octreotide 100micrograms/mL injection solution 1mL ampule Has specific active ingredient False Octreotide acetate Inferred relationship Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start